Consistent with these studies and in light of our findings, it is therefore plausible to hypothesize that, at least in AD, the reduced levels of DNA-PKcs activity, mediated by beta-amyloid, can determine the reduction of PSD-95 through the lack of its phosphorylation and the consequent proteasomal degradation. The gene discussed is DLG4; the disease is Alzheimer disease.